Aligos Therapeutics Inc. (NASDAQ: ALGS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ALIGOS THERAPEUTICS INC.

Aligos Therapeutics Inc. (NASDAQ: ALGS)
Listen to this Section


$4.96
-0.3850 ( -7.21% ) 70.8K

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Clinical Trial Pipeline Stages


Drug Name Stage
ALG-097558DetailsCOVID-19 Phase 2
ALG-000184 (Capsid Assembly modulator)DetailsChronic hepatitis B Phase 1
ALG-010133 (S-antigen Transport-inhibiting Oligonucleotide Polymer)DetailsChronic hepatitis B Failed
ALG-125755DetailsChronic hepatitis B, Liver disease Failed

Market Data


Open $4.96
Previous Close $5.34
Volume 70.8K
Market Cap $31.81M
Day Range $4.86 - $5.41
52 Week Range $4.86 - $13.69
Shares Outstanding 6.19M
Change % -7.21%
Net Change ▼ -0.3850
Insider Ownership -0.04%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 3,713,003.00

Date Type Amount Purchased Purchaser
2024-08-09 Sale -120000.00 Preston Heather
2024-08-09 Sale -120000.00 Chavez Margarita
2024-06-28 Sale -60000.00 Hirth Peter
2024-06-28 Sale -60000.00 Scopa James Paul
2024-06-28 Sale -60000.00 Martell Bridget A
2024-06-28 Sale -60000.00 Nuechterlein Carole
2024-03-04 Sale -72000.00 McClure Matthew W.
2024-03-04 Sale -72000.00 Symons Julian A.
2024-03-04 Sale -308940.00 Calhoun Lesley Ann
2024-03-04 Sale -965435.00 BLATT LAWRENCE

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 18, 2025
4 Insider transactions 1 Jul 18, 2025
4 Insider transactions 1 Jul 18, 2025
8-k 8K-related 14 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025
4 Insider transactions 1 Jun 26, 2025

Latest News


× Before browsing our site, please accept our cookies policy